PMCF study to further substantiate the effectiveness and safety of OSTENIL® TENDON in the overall as well as indication-specific treatment of pain and restricted mobility in four different tendon disorders (patella tendon, peroneal tendon, medial epicondylus humeri and iliotibial band) in a real-life clinical setting when used according to the instructions for use.
Patient aged between 18 and 99 years
Diagnosis of symptomatic tendinopathy (patella tendon, peroneal tendon, medial epicondylus humeri or iliotibial band)
Physician's recommendation to use OSTENIL® TENDON prior to recruitment
Signed informed consent
Presence of any contra-indication or precautionary condition listed in the instructions for use, i.e.,
Ascertained hypersensitivity to any of the OSTENIL® TENDON constituents
Known pregnancy or breast feeding
Acute trauma